Resource Center bioMérieux Worldwide Our Specific Websites Search form Search India Need information ? Contact us Main menu CLINICAL DIAGNOSTICS INDUSTRIAL MICROBIOLOGY NEWS & EVENTS RESOURCES ABOUT US MY SELECTION () PIONEERING DIAGNOSTICS bioMérieux India | Pioneering diagnostics LATEST NEWS 24.02.2021 bioMérieux – 2020 Financial Results 02.09.2020 First-Half 2020 Results 06.05.2020 bioMérieux serology tests for SARS-CoV-2 on VIDAS® undergo validation preceding imminent launch 24.02.2017 bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis 06.10.2016 bioMérieux introduces EviSight™ Compact, a new automated diagnostic solution for microbial detection in pharmaceutical production CLINICAL SOLUTIONS Products & Services Learn more about bioMérieux’s Clinical Products & Services Solutions Discover our solutions to current key problem areas Your Challenges Did you know we address the issues of labs, physicians and healthcare executives? INDUSTRIAL SOLUTIONS Food Solutions for Food safety & Food quality Biopharma Microbial Control Solutions for bioPharmaceutical Industries Veterinary Solutions for Veterinary Diagnostics Cosmetics Microbial Control Solutions for Cosmetics & Personal Care Industries OUR COMMUNITIES Resource Center Like us on Facebook Follow us on Twitter Discover our Youtube channel DISCOVER ALL OUR WEBSITES OUR WEBSITES bioMérieux Clinical Diagnostics bioMérieux Industry bioMérieux Corporate bioMérieux Investors bioMérieux Recruitment CLINICAL DIAGNOSTICS INDUSTRIAL MICROBIOLOGY NEWS & EVENTS RESOURCES ABOUT US MY SELECTION bioMérieux India Private Limited 43A, Okhla Phase-3, New Delhi – 110020, INDIA Legal Notice Privacy Cookie Policy Sitemap Contact Copyright 2018 bioMérieux SA

EN FR Search form Search Main menu ABOUT US RESPONSIBILITY SOLUTIONS EXPERTISE EDUCATION INVESTORS NEWSROOM CAREERS CONTACT US bioMérieux Corporate Website | PHILANTHROPY Watch the achievements of projects we have been supporting for 1 year! CORPORATE SOCIAL RESPONSIBILITY Our CSR ambition and commitments to improve our positive impact. COVID-19 FAQ on our commitment to fight against COVID-19 INVESTORS Discover our investors-dedicated section PRESS RELEASES October 21, 2021 Baxter and bioMérieux announce CE mark for NEPHROCLEAR™ CCL14 te... October 21, 2021 bioMérieux – Third-Quarter 2021 Business Review September 13, 2021 A survey in 5 European countries about sepsis demonstrates the lack... September 01, 2021 bioMérieux – First-Half 2021 Results PIONEERING DIAGNOSTICS bioMérieux Worldwide > Our Specific Websites > Our communities > LEGAL NOTICE PRIVACY COOKIE POLICY CONTACT Copyright 2021 bioMérieux SA biomerieux.com